Sebi board sidesteps allegations on chairperson Madhabi Puri Buch

Sebi board sidesteps allegations on chairperson Madhabi Puri Buch



The Securities and Exchange Board of India (Sebi) board meeting on Monday was expected to address allegations of disclosure lapses and conflicts of interest against chairperson Madhabi Puri Buch. However, two board members revealed that the issue was not discussed. This silence has disappointed some participants, particularly given the persistent allegations from the main opposition Congress party. Former officials and legal experts note that the Sebi board has limited scope to act on this matter.


“Chairpersons and whole-time members (WTMs) are appointed by the government. Only the government has the authority to take disciplinary action against them. Unlike a typical company board, they cannot be removed or penalised by the board. Even in cases of apparent conflict of interest, the board lacks the power to initiate formal proceedings,” explained a former chairperson of Sebi on condition of anonymity.

Click here to connect with us on WhatsApp

 


While the official agenda did not list the conflict of interest issue, sources suggest that it might still be discussed informally. “Between the last board meeting and Monday’s meeting, any significant event concerning the institution, its board members, including the chairperson, has to be taken note of by the board,” said a person familiar with the matter.


While conflict of interest allegations were never part of the official board meeting agenda, a clause in the Sebi rule book that ‘any significant event since the previous meeting concerning the market can be taken note of by the board’ had sparked speculation that the board would take up the issue.


At present, Sebi has eight board members, including the chairperson and four WTMs. The external or part-time members are Ajay Seth, Secretary, Department of Economic Affairs (DEA); Rajeshwar Rao, Deputy Governor, Reserve Bank of India; and Deepti Gaur Mukerjee, Secretary, Ministry of Corporate Affairs.


“This is a matter of regulatory governance by the government. It’s possible that the issue was discussed but not disclosed in the press release, as not all discussions on every agenda are shared publicly. If indeed the board didn’t address the matter, it could be due to an internal process or an ongoing review by the DEA, delaying immediate board-level consideration. As market speculation grows, the finance ministry must communicate the procedural steps being taken to avoid further uncertainty,” said Sumit Agrawal of Regstreet Law Advisors and former Sebi officer.


Governance experts suggest that a statement or clarification from the Sebi board on the allegations would have helped mitigate the negative perception and address concerns.


“While the Sebi board may not be empowered to act against the chairperson, they could have still at least discussed the issue of conflict of interest more proactively. This would have helped overcome the perception that the regulator is shirking the issue. While the chairperson has refuted all the allegations, the Sebi board as an entity too could have discussed the issue,” said Shriram Subramanian, founder and managing director of InGovern Research Services.


The Congress has been firing salvos against the chairperson, alleging violation of the code of conduct and a conflict of interest on account of payments received by Buch from her former employer ICICI Bank. Additionally, they have alleged that Buch, her husband Dhaval Buch, and their consultancy firm Agora Advisory were paid by corporates in return for favours.


Buch and her husband have refuted the allegations by the opposition party in a six-page letter, calling the claims false, malicious, and motivated.

First Published: Oct 01 2024 | 5:25 PM IST



Source link

Benchmarks slide for 3rd day, NSE VIX slips below 12 mark

Benchmarks slide for 3rd day, NSE VIX slips below 12 mark


The domestic benchmark indices declined for the third consecutive session on Tuesday with Nifty slipping below 25,800. Media, IT and auto shares climbed.The recent surge in Chinese equities, fueled by hopes of a recovery, has led to significant fund flows into the region.

The S&P BSE Sensex fell 33.49 points or 0.04% to 84,266.29. The Nifty 50 index shed 13.95 points or 0.05% to 25,769.90. The 50-unit index has corrected 1.70% in three straight sessions.

Click here to connect with us on WhatsApp

Titan Company (down 0.83%), Reliance Industries (down 0.81%) and HDFC Bank (down 0.34%) were major drags.

The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.27% and the S&P BSE Small-Cap index added 0.56%.

 

The market breadth was positive. On the BSE, 2,296 shares rose and 1,668 shares fell. A total of 90 shares were unchanged.

The NSE’s India VIX, a gauge of the market’s expectation of volatility over the near term, dropped 6.25% to 11.99.

The domestic stock market will be shut on Wednesday, 2 October 2024, in observance of Mahatma Gandhi Jayanti.

Economy:

India’s fiscal deficit remained under control during April-August, reaching 27% of the full-year target. This containment was attributed to muted spending in the early months of the fiscal year. The government’s spending has been lower due to general elections. In comparison, the deficit stood at a higher 36% during the same period in FY24.

The seasonally adjusted HSBC India Manufacturing Purchasing Managers Index (PMI) fell from 57.5 in August to 56.5 in September, highlighting a robust improvement in the health of the sector that was nonetheless the weakest since January.

Numbers to watch:

The yield on India’s 10-year benchmark federal paper rose 1.41% to 6.845 from its previous close of 6.865.

In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 83.8250, compared with its close of 83.7925 during the previous trading session.

MCX Gold futures for 4 October 2024 settlement added 0.34% to Rs 75,506.

The US Dollar index (DXY), which tracks the greenback’s value against a basket of currencies, was up 0.33% to 101.11.

The United States 10-year bond yield declined 1.65% to 3.745.

In the commodities market, Brent crude for December 2024 settlement declined 31 cents or 0.43% to $71.70 a barrel.

Global Markets:

Dow Jones Futures were down 80 points, indicating a negative opening in the US stock market today.

Most European stocks rose today as Euro zone inflation fell below 2% for the first time since mid-2021, preliminary data showed Tuesday, likely boosting the chances of another interest rate cut from the European Central Bank.

Asian stocks ended mixed after Federal Reserve Chair Jerome Powell indicated the recent outsized cuts enacted by the U.S. central bank should not be interpreted as a sign that future moves will be as aggressive. The U.S. dollar strengthened in response. Meanwhile, heightened tensions in the Middle East added to market uncertainty.

With mainland China’s financial markets closed for the remainder of the week, the recent rally in Asian markets is expected to pause. Hong Kong’s Hang Seng is also closed on Tuesday.

Japan reported its unemployment rate for August eased to 2.5%, down from 2.7% in July

U.S. equities closed higher on Monday, recovering from earlier losses triggered by Powell’s remarks. The Dow Jones Industrial Average rose by 0.04% to a record closing high of 42,330.15. The S&P 500 gained 0.42% to also reach a new record close of 5,762.48. The Nasdaq Composite added 0.38%.

Investors had anticipated more aggressive rate cuts from the Federal Reserve in its final two meetings of the year. However, Powell indicated that the central bank would likely stick to quarter-point rate reductions moving forward, citing recent economic data that showed strong growth and consumer spending.

September Auto Sales Impact:

Tata Motors shed 1%. The car majors domestic and international vehicle sales declined 11.52% to 2,15,034 units in September 2024 as against 2,43,024 units sold in September 2023.

Bajaj Auto fell 1.3%. The company reported 19.60% jump in total auto sales to 4,69,531 units in September 2024 as against 3,92,558 units in September 2023.

Escorts Kubota declined 1.7%. The tractor manufacturer announced that its agri machinery business division sales grew by 2.47% to 12,380 units in September 2024 as against 12,081 units sold in September 2023.

Further, the companys construction equipment business division sold 510 machines in September 2024, registering de-growth of 18.7% from 627 machines sold in September 2023.

Ashok Leyland added 1.23% after the company has reported total vehicle sales of 17,233 units for the month of September 2024, which is lower by 10% as compared with the sales of 19,202 units sold in September 2023.

Steel Strips Wheels added 0.7% after the company said that it has achieved monthly net turnover of Rs 362.12 crore, which is lower by 9.89% as compared with the figure of Rs 401.88 crore recorded in September 2023.

TVS Motor Company shed 0.05%. The company said that it has recorded monthly sales of 482,495 units in September 2024 with a growth of 20% as against 402,553 units in the month of September 2023.

Stocks in Spotlight:

Vipul Organics hit an upper circuit of 19.56% to Rs 311.75 after the companys right issue committee approved raising Rs 25 crore through right issue of equity shares. The company will offer 1 share for every 3 shares held on record date at a premium of Rs 44 for the share of face value Rs 10 (total price Rs 54).

Senco Gold jumped 4.15% after the company said its board will mull fund raising and stock split on 4 October 2024.

Angel One rose 1.50% after introducing transaction charges on delivery-based equity trades with effect from November 1st this year.

Andhra Cements soars 10% to Rs 94.635 after the company files the draft papers with the Securities and Exchange Board of India (SEBI) to raise up to Rs 180 crore through a rights issue.

BASF India spurted 7.15%, rising for the fifth day to hit a record high of Rs 8249.90 today. Last week, the company’s German parent announced a new global strategy, “Winning Ways,” which aims to focus, accelerate, transform, and win.

National Aluminium Company jumped 6.54% to hit a record high of Rs 227.35 today after a broker upgraded its rating to ‘add’ and raised its price target to Rs 235. The broker cited the company’s strong position in the alumina market as a key positive.

Eraaya Lifespaces jumps 5% after the company announced a strategic restructuring following the Ebix, Inc. acquisition. The company declared control, reaffirms continuity and integration of operations. It initiated an investigation into financial irregularities, while suspending Robin Raina pending inquiry.

Godrej Properties advanced 3.11% after the company announced that its board has approved raising up to Rs 6,000 crore through various methods in one or more tranches

GE Power India advanced 2.24% after the company announced that it has received a contract worth Rs 240.4 crore (NPR 340 million) from Blue Energy in Nepal.

Zydus Lifesciences added 1.10% after the company announced that it has received the establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA) for its transdermal patch manufacturing facility Pharmez, Ahmedabad. The USFDA conducted an inspection from 15 to 19 July 2024, and has been classified as Voluntary Action Indicated (VAI).

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content



Source link

Sebi to announce F&O curbs soon; changes to be enacted via circular

Sebi to announce F&O curbs soon; changes to be enacted via circular



The much-awaited overhaul of derivatives trading criteria didn’t form part of the 17-point agenda of Sebi’s latest board meeting. However, regulatory sources said the curbs—first proposed through a discussion paper in July—could be enacted by way of a circular “soon.”


The market regulator had proposed seven key measures to curb retail participation in index futures and options (F&O) to limit losses.

Click here to connect with us on WhatsApp


A source familiar with the developments said the consultation paper floated was in the form of a draft circular and not draft regulation. As a result, Sebi’s post-board meeting 23-page press release was silent on it.

 


Sebi whole-time member Ashwani Bhatia also affirmed that the changes might be issued soon to several news outlets in New Delhi on the sidelines of Local Governance Synergy Conclave, jointly organised by the Office of Comptroller and Auditor General of India (ICAI) and the Institute of Chartered Accountants of India (ICAI).


Market players, including the stock exchanges which will be impacted by the proposed changes, had submitted their suggestions on the higher entry barriers, limiting single benchmark per exchange for weekly expiry, and margin requirements.


The market regulator had received overwhelming response on the proposals and the F&O traders have been on the edge on the proposed changes taking the final shape.


Futures Industry Association (FIA), an global trade body representing interests of traders in the derivatives market, had also in its response recommended “cautious and conservative approach”.  


“The potential for the proposed measures to inadvertently produce counterproductive outcomes should be thoroughly evaluated. For example, increased ELM (Extreme Loss Margin) measures could disproportionately penalize conservative options strategies (e.g., call, put, and calendar spreads), leading investors towards riskier strategies that now incur similar margin costs,” submitted FIA. 


It added that a substantial reduction in expiries and strikes may concentrate the market in fewer financial instruments, limiting investor choice and impacting the precision and cost effectiveness of strategies.


In its board meeting held on Monday, the market regulator’s board—which has members from the Reserve Bank of India (RBI) and the government—gave nod to several key decisions including overhaul of investment advisor regulations, faster rights issue, pro-rata and pari-passu rights of investors of Alternative Investment Funds (AIFs).

First Published: Oct 01 2024 | 5:08 PM IST



Source link

Benchmarks slide for 3rd day, NSE VIX slips below 12 mark

KRN Heat Exchanger and Refrigeration IPO ends with more than 214x subscription


The offer received bid for 2.35 crore shares as against 1.09 crore shares on offer.

The initial public offer (IPO) of KRN Heat Exchanger and Refrigeration received bids for 2,35,71,39,005 shares as against 1,09,93,000 shares on offer. The issue was subscribed 214.42 times.

The Qualified Institutional Buyers (QIBs) category was subscribed 253.04 times. The Non Institutional Investors (NIIs) category was subscribed 431.63 times. The Retail Individual Investors (RIIs) category was subscribed 98.29 times.

Click here to connect with us on WhatsApp

The issue opened for bidding on Wednesday (25 September 2024) and it will close on Friday (27 September 2024). The price band of the IPO was fixed between Rs 209 to 220 per share. An investor can bid for a minimum of 65 equity shares and in multiples thereof.

 

The IPO comprises fresh issue of equity shares of 1,55,23,000 equity share of Rs 10 face value.

Of the net proceeds from the fresh issue, about Rs 242.46 crore will be used towards investment in equity of KRN HVAC Products (a wholly owned subsidiary of the company) which is setting up a new manufacturing facility at Neemrana and the balance of net proceeds is used for general corporate purposes.

Ahead of the IPO, KRN Heat Exchanger and Refrigeration on Tuesday, 24 September 2024, raised Rs 100.10 crore from anchor investors. The board allotted 45.50 lakh shares at Rs 220 each to 10 anchor investors.

KRN Heat Exchanger and Refrigeration (KHERL), promoted by Santosh Kumar Yadav, manufactures fin and tube type heat exchangers for the Heat Ventilation Air Conditioning and Refrigeration Industry (HVAC&R). It acts as an OEM supplier for the HVAC industry in India, specializing in manufacturing heat exchangers used in commercial air-conditioning and packaging air conditioning products such as process cooling equipment, data cooling centers, railways/metros, and other commercial air conditioning units.

The firm reported a consolidated net profit of Rs 39.07 crore and Sales of Rs 308.28 crore for the twelve months ended on 31 March 2024.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:56 PM IST



Source link

Benchmarks slide for 3rd day, NSE VIX slips below 12 mark

Nifty October futures trade at premium


NSE India VIX tumbled 6.25% to 11.99.

The Nifty October 2024 futures closed at 25,976.40, a premium of 179.5 points compared with the Nifty’s closing 25,796.90 in the cash market.

In the cash market, the Nifty 50 shed 13.95 points or 0.05% to 25,796.90.

Click here to connect with us on WhatsApp

The NSE’s India VIX, a gauge of the market’s expectation of volatility over the near term, dropped 6.25% to 11.99.

HDFC Bank, State Bank of India and Reliance Industries were the top traded individual stock futures contracts in F&O segment of NSE.

The October 2024 F&O contracts will expire on 31 October 2024.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:32 PM IST



Source link

Benchmarks slide for 3rd day, NSE VIX slips below 12 mark

Aurobindo Pharma receives USFDA approval for Cephalexin Tablets


Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Keflet Tablets, 250 mg and 500 mg, of Eli Lilly and Company.

Aurobindo Pharma was granted Competitive Generic Therapy (CGT) designation for Cephalexin Tablets USP, 250 mg and 500 mg, and is eligible for 180 days of shared generic drug exclusivity. The product is expected to be launched in Q3FY25.

Click here to connect with us on WhatsApp

Cephalexin Tablets USP, 250 mg and 500 mg are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms.

 

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Oct 01 2024 | 4:30 PM IST



Source link

YouTube
Instagram
WhatsApp